DVDaphne P. C. Vergouwen

Daphne P. C. Vergouwen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Daphne P. C. Vergouwen has a total of 50 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    PARADOXICAL EXACERBATION OF SCLEROUVEITIS AFTER RITUXIMAB INFUSION

    by Daphne P. C. Vergouwen, Maud A. W. Hermans, Lise Sels

    Purpose: To report on an unexpected side effect of rituximab, a B-cell–targeting monoclonal agent, in a patient with severe sclerouveitis, leading to severe visual loss. Methods: Observational case report. Results: A 61-year-old female patient was treated with rituximab for a severe sclerouveitis occurring with granulomatosis with polyangiitis. Initially, sclerouveitis responded partly to a high dose of oral corticosteroids. However, her sclerouveitis recurred after 2 months during tapering below 20 mg daily. The days following the rituximab infusions, aggravation of the intraocular inflammation was seen, endangering visual acuity. No evidence for an infection or other cause was found. High doses of oral corticosteroids were started within one week, whereafter the ocular inflammation resolved. For persisting hypotony and chorioretinal detachment, a combined pars plana vitrectomy with phacoemulsification and silicone oil tamponade was performed. The retina remained attached under oil tamponade with partial improvement of the best-corrected visual acuity to finger counting. Conclusion: Ophthalmologist should be aware of the possibility of this paradoxical local reaction to rituximab infusion, particularly in bilateral and/or severe cases, which carry a risk of a poor outcome.


  • Open Access

    The enigma of sclera-specific autoimmunity in scleritis

    by Daphne P.C. Vergouwen, Adriaan A. van Beek, Joeri de Hoog, Joke H. de Boer, Leonoor I. Los, Marlies Gijs, Roel J. Erckens, Rob M. Verdijk, Geert W. Haasnoot, Dave L. Roelen, et al.


  • Open Access

    Assessment of conjunctival, episcleral and scleral thickness in healthy individuals using anterior segment optical coherence tomography

    by G. J. Teeuw, D. P. C. Vergouwen, W. D. Ramdas, L. Sanchez‐Brea, D. Andrade De Jesus, A. Rothova, J. R. Vingerling, J. C. Ten Berge

    Purpose: To determine the thickness of the conjunctiva, episclera and sclera in healthy individuals using anterior segment optical coherence tomography (AS-OCT).Methods: We prospectively included 107 healthy individuals of different age groups (18-39 years, 40-54 years, 55-69 years and >= 70 years). For each eye, AS-OCT scans of four quadrants (temporal, nasal, superior and inferior) were acquired. The thickness of the conjunctiva, episclera and sclera was measured for each scan. In addition, the axial length of both eyes was measured, and general characteristics, including smoking, allergies and contact lens use, were collected.Results: The mean conjunctival thickness was significantly different between the nasal and superior quadrants (87 +/- 30 mu m vs. 77 +/- 16 mu m; p < 0.001), as well as the superior and inferior quadrants (77 +/- 16 mu m vs. 86 +/- 19 mu m; p = 0.001). The mean episcleral thickness was larger in the superior (174 +/- 54 mu m) and inferior (141 +/- 43 mu m) quadrants, compared to the nasal (83 +/- 38 mu m) and temporal quadrants (90 +/- 44 mu m). The mean scleral thickness of the inferior quadrant was the largest (596 +/- 64 mu m), followed by the nasal (567 +/- 76 mu m), temporal (516 +/- 67 mu m) and superior (467 +/- 52 mu m) quadrants (all p < 0.001). The averaged scleral thickness increased 0.96 mu m per age year (0.41-1.47 mu m, p < 0.001).Conclusions: This study provides an assessment of the thickness of scleral and adjacent superficial layers in healthy individuals determined on AS-OCT, which could enable future research into the use of AS-OCT in diseases affecting the anterior eye wall.


  • Open Access

    Potential Biomarkers for Noninfectious Scleritis Identified by Serum and Tear Fluid Proteomics

    by Daphne P.C. Vergouwen, P. Martijn Kolijn, Joeri de Hoog, Joke H. de Boer, Leonoor I. Los, Marlies Gijs, Roel J. Erckens, Pascal H.P. de Jong, Aniki Rothova, Josianne C. Ten Berge, et al.


  • Open Access

    Evaluation of pre-processing methods for tear fluid proteomics using proximity extension assays

    by Daphne P. C. Vergouwen, Amber J. Schotting, Tanja Endermann, Harmen J. G. van de Werken, Dwin G. B. Grashof, Sinthuja Arumugam, Rudy M. M. A. Nuijts, Josianne C. Ten Berge, Aniki Rothova, Marco W. J. Schreurs, et al.

    Tear fluid forms a potential source for biomarker identification, and can be minimal invasively collected via Schirmer strips. The lack of knowledge on the processing of Schirmer strips however complicates the analysis and between-study comparisons. We studied two different pre-processing methods, specifically the use of punches of the strip versus elution of the strip in a buffer. Tear fluid filled Schirmer strips were collected from 5 healthy participants, and divided into two halves over the length of the strip. In either part, punches or eluates were obtained from 4 different locations, from the first part touching the eye (head) to the end, to assess the protein distribution along the strips. The levels of 92 inflammatory proteins were measured in the punches/eluates using proximity extension assays. The punch method yielded higher protein detectability compared to the elution method (76% vs 66%; p ≤ 0.001). Protein expression level was found to be slightly higher in the head of the strip, however, 3 out of 5 punches from the head failed quality control. Protein expression levels over the remaining parts of the strips were similar. Our study showed beneficial use of punches of any part of the strip except the head in future biomarker research.


  • Open Access

    Scleral Proteome in Noninfectious Scleritis Unravels Upregulation of Filaggrin-2 and Signs of Neovascularization

    by Daphne P. C. Vergouwen, Josianne C. Ten Berge, Coskun Guzel, Thierry P. P. van Den Bosch, Robert M. Verdijk, Aniki Rothova, Theo M. Luider, Marco W. J. Schreurs

    Purpose: Scleritis is a severe inflammatory ocular disorder with unknown pathogenesis. We investigated healthy sclera as well as sclera affected by noninfectious scleritis for differentially expressed proteins using a mass spectrometry approach. Methods: We collected scleral samples of enucleated eyes due to severe noninfectious scleritis (n = 3), and control scleral tissues (n = 5), all exenterated eyes for eyelid carcinomas (n = 4), or choroidal melanoma (n = 1) without scleral invasion. Samples were prepared for the nano liquid-chromatography mass spectrometer (LC-MS), data were analyzed using proteomics software (Scaffold), and is available via ProteomeXchange (identifier PXD038727). Samples were also stained for immuno-histopathological evaluation. Results: Mass spectrometry identified 629 proteins within the healthy and diseased scleral tissues, whereof collagen type XII, VI, and I were the most abundantly expressed protein. Collagen type II-XII was also present. Filaggrin-2, a protein that plays a crucial role in epidermal barrier function, was found upregulated in all scleritis cases. In addition, other epithelial associated proteins were upregulated (such as keratin 33b, 34, and 85, epiplakin, transglutaminase-3, galectin 7, and caspase-14) in scleritis. Further, upregulated proteins involved in regulation of the cytoskeleton (vinculin and myosin 9), and housekeeping proteins were found (elongation factor-2 and cytoplasmic dynein 1) in our study. Upregulation of filaggrin-2 and myosin-9 was confirmed with immunohistochemistry, the latter protein showing co-localization with the endothelial cell marker ETC-related gene (ERG), indicating neovascularization in scleral tissue affected by scleritis. Conclusions: We found upregulation of filaggrin-2 and signs of neovascularization in scleral tissue of patients with noninfectious scleritis. Further research, ideally including more scleritis cases, is needed to validate our findings.


  • Open Access

    Scleritis in rheumatoid arthritis: Before and during biologic era

    by Daphne P. C. Vergouwen, Pascal H. P. de Jong, Marco W. J. Schreurs, Josianne C. Ten Berge, Aniki Rothova

    Objectives: Scleritis represents a severe extra-articular manifestation of rheumatoid arthritis (RA). Recent clinical observations suggest a decreasing incidence of scleritis in RA, attributed to improved treatment options. Our study reports on the incidence and clinical characteristics of scleritis in RA observed in the biological era and reflects on our results in a historical perspective.Methods: We performed a retrospective evaluation of all 1623 consecutive patients with RA diagnosed at the department of rheumatology between 2011 and 2021 at the Erasmus Medical Center to investigate the incidence of scleritis. We also reviewed clinical and laboratory data of all patients with scleritis and RA from the department of ophthalmology at our center. In addition, we reviewed the literature on this topic and discuss our results in view of changes over time.Results: The incidence of scleritis within recent series of patients with a diagnosis of RA in our tertiary center was 0,25% in 10 years (4 out of 1623; 2011-2021).The cumulative incidence of scleritis in RA based on literature review from the pre-biologic era varied from 0.7% per 8 years to 0,8% per 30 years. Manifestations and complications of scleritis remained unchanged over time, with scleral necrosis developing in more than 80% of cases and mortality of RA patients with scleritis remained similar to pre-biologic era (30% in 9 years after the onset of scleritis). The RA patients with scleritis often exhibited autoantibodies (rheumatoid factor and/or anti-citrullinated protein antibody) and erosive disease.Conclusion: Although our recent series is characterized by a slightly lower incidence of scleritis in RA compared to the pre-biologic era, clinical presentation remained severe and similar to the pre-biologic era. Ophthalmologists and rheumatologists should be aware of scleritis as a severe extra-articular manifestation of RA.


  • Open Access

    Evaluation of pre-processing methods for tear fluid proteomics using the Olink platform

    by Daphne P.C. Vergouwen, Amber J. Schotting, Tanja Endermann, Harmen J.G. Van de Werken, Dwin G.B. Grashof, Sinthuja Arumugam, Rudy M.M.A. Nuijts, Josianne C. Ten Berge, Aniki Rothova, Marco W.J. Schreurs, et al.

    Tear fluid forms a potential source for biomarker identification, and can be minimal invasively collected via Schirmer strips. The lack of knowledge on the processing of Schirmer strips however complicates the analysis and between-study comparisons. We studied two different pre-processing methods, specifically the use of punches of the strip versus elution of the strip in PBS buffer. Tear fluid filled Schirmer strips were collected from 5 healthy participants, and divided into two halves over the length of the strip. In either part, punches or eluates were obtained from 4 different locations, from the first part touching the eye (head) to the end, to assess the protein distribution along the strips. The levels of 92 inflammatory proteins were measured in the punches/eluates using Olink Target 96. The punch method yielded higher protein detectability compared to the elution method (76% vs 66%; p ≤ 0.001). However, 3 out of 5 punches from the head failed quality control. Protein levels over the remaining parts of the strips were similar. Based on our findings we encourage using the punch method of any part of the strip except the head with Olink Target 96 or other suitable techniques.

  • Subconjunctival Rituximab Administration for the Treatment of Scleritis

    by D. P. C. Vergouwen, J. C. Ten Berge, N. C. Naus-Postema, A. Rothova

    Scleritis is a sight-threatening inflammation, which is commonly accompanied by severe complications. Aggressive systemic immunosuppressive treatment, which is frequently needed, can be associated ...


  • Open Access

    Clinical Relevance of Autoantibodies and Inflammatory Parameters in Non-infectious Scleritis

    by D.P.C. Vergouwen, J.C. Ten Berge, S. Boukhrissi, A. Rothova, M.W.J. Schreurs

    Scleritis is a potentially blinding disorder, with highly unpredictable course and outcome. We analyzed the prevalence and clinical relevance of autoantibodies and inflammatory parameters in non-in...